The  	The  	 DT	O
Way  	Way  	 NNP	O
Forward 	Forward 	 NNP	O
:  	:  	 :	O
Practical  	Practical  	 NNP	B-NP
Clinical  	Clinical  	 NNP	I-NP
Considerations  	Considerations  	 NNP	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
Use  	Use  	 NN	O
of  	of  	 IN	O
Canakinumab  	Canakinumab  	 NNP	B-NP
in  	in  	 IN	O
Patients  	Patients  	 NNS	O
With  	With  	 IN	O
Difficult-to-Treat  	Difficult-to-Treat  	 NNP	B-NP
Gouty  	Gouty  	 NNP	I-NP
Arthritis  	Arthritis  	 NNP	I-NP
Canakinumab  	Canakinumab  	 NNP	I-NP
is  	is  	 VBZ	O
indicated  	indicated  	 VBN	O
for  	for  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
frequent  	frequent  	 JJ	O
gouty  	gouty  	 JJ	O
arthritis  	arthritis  	 NN	B-NP
attacks  	attacks  	 NNS	I-NP
who  	who  	 WP	O
cannot  	cannot  	 RB	O
be  	be  	 VB	O
managed  	managed  	 VBN	O
with  	with  	 IN	O
standard-of-care  	standard-of-care  	 JJ	B-NP
medication 	medication 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
should  	should  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
labeled  	labeled  	 JJ	O
indication 	indication 	 NN	O
.  	.  	 .	O
Given  	Given  	 VBN	O
its  	its  	 PRP$	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
action 	action 	 NN	O
,  	,  	 ,	O
physicians  	physicians  	 NNS	O
need  	need  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
aware  	aware  	 JJ	O
of  	of  	 IN	O
the  	the  	 DT	O
potential  	potential  	 JJ	B-NP
contraindications  	contraindications  	 NN	I-NP
and  	and  	 CC	O
precautions  	precautions  	 NNS	O
with  	with  	 IN	O
its  	its  	 PRP$	O
use 	use 	 NN	O
.  	.  	 .	O
When  	When  	 WRB	O
deciding  	deciding  	 VBG	O
as  	as  	 RB	O
to  	to  	 TO	O
whether  	whether  	 IN	O
a  	a  	 DT	O
patient  	patient  	 NN	O
with  	with  	 IN	O
gouty  	gouty  	 JJ	O
arthritis  	arthritis  	 NN	O
is  	is  	 VBZ	O
an  	an  	 DT	O
appropriate  	appropriate  	 JJ	O
candidate  	candidate  	 NN	O
for  	for  	 IN	O
canakinumab  	canakinumab  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
several  	several  	 JJ	O
key  	key  	 JJ	O
clinical  	clinical  	 JJ	B-NP
considerations  	considerations  	 NNS	I-NP
should  	should  	 MD	O
be  	be  	 VB	O
kept  	kept  	 VBN	O
in  	in  	 IN	O
mind 	mind 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
are  	are  	 VBP	O
discussed  	discussed  	 VBN	O
herein 	herein 	 NN	O
.  	.  	 .	O
